Krka Logo

Krka

Develops and sells generic prescription, non-prescription, and animal health products globally.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Krka is a leading international generic pharmaceutical company focused on the development, production, marketing, and sale of human and animal health products. With over 70 years of experience, the company's core business is providing high-quality and innovative generic medicines. Its portfolio is composed of three main segments: prescription pharmaceuticals for treating common diseases, non-prescription products for minor illnesses and preventative care, and a range of animal health products. Krka's products are marketed globally, serving patients in more than 70 countries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 08:30
Regulatory News Service
Conclusion regarding perindopril litigation
English 1.4 KB
2025-10-08 08:30
Regulatory News Service
Odločitev Komisije EU v zadevi perindopril
Slovene 1.4 KB
2025-09-29 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 142.3 KB
2025-09-29 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-29 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 137.5 KB
2025-09-29 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-09-22 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 124.7 KB
2025-09-22 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-22 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 122.2 KB
2025-09-22 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-09-19 08:30
Board/Management Information
Konstitutivna seja nadzornega sveta Krke, d. d., Novo mesto
Slovene 1.4 KB
2025-09-19 08:30
Board/Management Information
Constitutive session of the Supervisory Board of Krka, d. d., Novo mesto
English 1.4 KB
2025-09-15 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 133.3 KB
2025-09-15 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-15 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 130.6 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cellromax Science Co., Ltd. Logo
Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.
South Korea 471820
CellSeed Inc. Logo
Develops cell sheet products, culture equipment, and offers contract manufacturing services.
Japan 7776
CellSource Co.,Ltd. Logo
Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.
Japan 4880
Celltrion, Inc. Logo
A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.
South Korea 068270
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland CLN
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea 083790
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea 261780
Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea 052670
Chemical Works of Gedeon Richter Plc Logo
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
Hungary RICHT

Talk to a Data Expert

Have a question? We'll get back to you promptly.